InvestorsHub Logo

Ecomike

07/17/18 5:59 PM

#75404 RE: drugmanrx #75384

I have ridden through 3-4 R/S buying the bottom just before the R/S and did very very well. One is now on Nasdaq and Hit over $18/share, was and still is a biotech. Cramer was even pumping it at $18, I was telling folks to buy it at .0010 like I did. Trading about $12+ this year. The R/S was back in 2011-2012 ish.

Most R/S are failed companies with no revenue and no business and massive convertible debt.

SGSI has not printed shares in some time.

OS as of today is still 288.x Mil shares.

SGSI has 300 employees already, over 30 Mil in annual revenue rate and soon to be the one that plugs the plug fantasy imho.

I think the R/S is to enable the next two company purchases. I also suspect it may happen very soon, the news of massive 10-Q profits and then the third company purchase, all of which will rally the price to well over a .020 pre split price, with ease.